Imatinib:Medication for acute lymphoblastic leukemia
Created 1 month ago by anniepery

Imatinib is a protein-tyrosine kinase inhibitor drug. Healthcare professionals recommend this medicine in treating chronic myeloid leukemia, acute lymphoblastic leukemia, myelodysplastic/myeloproliferative diseases, aggressive systemic mastocytosis, hypereosinophilic syndrome, and chronic eosinophilic leukemia, dermatofibrosarcoma protuberans, gastrointestinal stromal tumors, etc. The medicine comes in the strength of 100 mg and 400 mg. This medicine comes in the form of tablets. In India, Imatinib 400 mg price is reasonable, and it is readily available with certified suppliers and pharmacies. To purchase this medicine of higher quality, call us on 18008891064.